Solid Biosciences reposted this
🌟 Learn more about Session Three of Hearts in Rhythm Organization Industry Panel Livestream on Friday, June 7th🌟 🕝 Time: 2:30 p.m. - 3:15 p.m. Eastern 📍 Tune in at: www.sads.ca/hiro2024 or click the link in our bio Session Three: Gene Therapies for Inherited Cardiac Disease Meet the speakers, Dr. Gabriel Brooks (Chief Medical Officer, Solid Biosciences) and Dr. Richie Khanna (Vice President of Nonclinical and Bioanalytical Development, Lexeo Therapeutics), along with moderators Dr. Chris Simpson (Executive Vice President and Chief Medical Executive, Ontario Health), Dr. Shubhayan Sanatani (Pediatric Electrophysiologist, BC Children's Hospital), and Mr. Evan Krueger (Communications Director, Canadian SADS Foundation). Explore the latest approaches for treating catecholaminergic polymorphic ventricular tachycardia (CPVT), focusing on therapies targeting the RYR-2 gene. Additionally, this session will highlight innovative gene therapy efforts aimed at addressing arrhythmogenic cardiomyopathy, specifically targeting the PKP-2 gene. Following the presentations, moderators will engage in a discussion to delve deeper into these groundbreaking therapies. Don't miss this opportunity to learn about the future of gene therapies for inherited cardiac disease! Disclaimer: The Canadian SADS Foundation does not endorse any specific therapeutic or pharmaceutical company. For any specific concerns regarding your health, please consult with your healthcare team.
